Add To Watchlist
Share URL
About The Company
Description
Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark.
Read More
Overview
Value
63
Growth
18
Health
39
Management
28
Analyst Opinion
86
Total
47
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a margin-of-safety above fair value
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Has a high level of debt
- Does not hold enough liquid assets to cover short term liabilities
- Poor earnings and cashflow growth
- Accounting anomalies: Growing revenues without a corresponding growth in cash flows. 0
Market Peers
ATT.ST
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
184.23%
Revenue Growth (5 Year Average)
4.71%
Ratings Consensus
Strong Buy
Share Buybacks
N/A
Dividend Yeild (TTM)
N/A
Valuation
Value Score
63
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 109.2 SEK ✔
Current Price: 26.3 SEK
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
26.98%
PE/Earnings Growth
N/A
Price/Book
0.84x
Growth
Growth Score
18
- ✔ Revenue growth has improved this yeara
- ✔ Earnings growth has improved this year
- ✘ 5 Year Average Revenue growth of 4.71% is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ 5 Year Average Free Cashflow growth of -7.08% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
4.71%
Earnings Growth
N/A
Cashflow Growth
-7.08%
Health
Health Score
39
Altman Z Score
0.78
Piostroski Score
4.00
Debt/Equity
2.81x
Current Assets/Liabilities
0.71x
Free Cashflow/Total Debt
0.09x
Debt/Capital
6.27x
Management
Management Score
28
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
0.02%
5 Year Price Volitility
12.56%
Return On Assets
0.27%
Return On Capital Employed
14.66%
Return On Equity
1.14%
Return On Free Cashflow
4.31%
Return On Investments
N/A
Analysts
Analyst Opinion
86
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Currency
SEK
Beta
Vol Avg
Ceo
Mr. Martin Folke Tiveus
Cik
Cusip
Exchange
Stockholm Stock Exchange
Full Time Employees
Industry
Medical Care Facilities
Sector
Healthcare
Ipo Date
Address
VendevAegen 85
City
Danderyd
State
Country
Zip
182 91
Phone
46 8 58 62 52 00
All financial data provided by FMP